You saw it on LinkedIn. Or heard it at a conference. Or your investor mentioned it in a board meeting with the tone that signals: we need to talk about this.
A competitor – one whose product is not demonstrably better than yours – just announced an institutional mandate. A real one. A bank, a fund, an asset manager. The kind of counterparty you've been trying to reach for a year.
Your first reaction: how? Your second reaction: what are we doing wrong?
The answer is uncomfortable but precise. They didn't have a better product. They had a better commercial infrastructure.
What the competitor actually built
Look past the announcement. Look at what had to exist for that deal to close:
- Someone – internal or external – who understood the institutional buyer's decision process and built the engagement around it
- A qualification system that identified this specific institution as a realistic target at this specific stage
- Institutional-grade documentation that survived due diligence without generating three months of back-and-forth
- A value proposition tailored to this institutional segment – not a generic "we're the best platform" pitch
- A follow-up discipline that kept the conversation alive through the 6-to-12-month decision cycle
- An internal champion at the institution who was armed with the materials to win the internal argument
None of this is talent. All of it is infrastructure. Your competitor may have had better people – or they may have had the same calibre of people operating within a system that multiplied their effectiveness.
The cascading effect
An institutional mandate in digital assets is not just one deal. It's a signal that cascades:
Market credibility. Other institutions see the announcement and add the competitor to their shortlist. The second mandate is easier than the first.
Fundraising leverage. Institutional revenue – even from a pilot – changes the conversation with investors. It de-risks the next round.
Talent attraction. Senior BD and commercial hires want to join the company that's winning institutional mandates, not the one that's trying to.
Competitive moat. Each institutional relationship creates switching costs. Once an institution is onboarded, the operational cost of switching is high. Your window narrows with every mandate your competitor closes.
The competitor who lands the first institutional mandate doesn't just win that deal. They change the game for every deal after it – including the ones that should have been yours.
What this moment requires
This is the moment most founders respond with urgency but not precision. They hire a BD person. They increase their conference budget. They start reaching out to institutional contacts without a plan. Activity increases. Results don't.
What this moment actually requires is a structural response:
Diagnosis first. What exactly is the gap between your current commercial capability and what's needed to close an institutional mandate? Not a general sense that "we need to do more BD" – a forensic assessment of what exists, what's missing, and what needs to be built.
Prioritisation. Not every institution is the right target. Not every segment is realistic at this stage. Which institutional buyers are reachable with what you have today, and what do you need to build to reach the next tier?
Infrastructure before activity. More meetings without better infrastructure produces the same result: promising conversations that die in due diligence. Build the machine first. Then run it.
The board conversation
If your board is asking about institutional traction – and they will, especially after a competitor's announcement – the worst answer is "we're working on it." The best answer is: "We've diagnosed the gap, we have a plan, and here's the timeline."
That requires having actually done the diagnosis. Not next quarter. Now. Because the window between a competitor's first institutional mandate and their second is exactly how long you have to catch up. After the second one, you're not catching up. You're playing a different game.